Display options
Share it on

PeerJ. 2020 Dec 11;8:e10396. doi: 10.7717/peerj.10396. eCollection 2020.

Driver versus navigator causation in biology: the case of insulin and fasting glucose.

PeerJ

Manawa Diwekar-Joshi, Milind Watve

Affiliations

  1. Biology, Indian Institute of Science Education and Research, Pune, Maharashtra, India.
  2. Deenanath Mangeshkar Hospital and Research Centre, Pune, Maharashtra, India.

PMID: 33365205 PMCID: PMC7735078 DOI: 10.7717/peerj.10396

Abstract

BACKGROUND: In biomedicine, inferring causal relation from experimental intervention or perturbation is believed to be a more reliable approach than inferring causation from cross-sectional correlation. However, we point out here that even in interventional inference there are logical traps. In homeostatic systems, causality in a steady state can be qualitatively different from that in a perturbed state. On a broader scale there is a need to differentiate driver causality from navigator causality. A driver is essential for reaching a destination but may not have any role in deciding the destination. A navigator on the other hand has a role in deciding the destination and the path but may not be able to drive the system to the destination. The failure to differentiate between types of causalities is likely to have resulted into many misinterpretations in physiology and biomedicine.

METHODS: We illustrate this by critically re-examining a specific case of the causal role of insulin in glucose homeostasis using five different approaches (1) Systematic review of tissue specific insulin receptor knock-outs, (2) Systematic review of insulin suppression and insulin enhancement experiments, (3) Differentiating steady state and post-meal state glucose levels in streptozotocin treated rats in primary experiments, (4) Mathematical and theoretical considerations and (5) Glucose-insulin relationship in human epidemiological data.

RESULTS: All the approaches converge on the inference that although insulin action hastens the return to a steady state after a glucose load, there is no evidence that insulin action determines the steady state level of glucose. Insulin, unlike the popular belief in medicine, appears to be a driver but not a navigator for steady state glucose level. It is quite likely therefore that the current line of clinical action in the field of type 2 diabetes has limited success largely because it is based on a misinterpretation of glucose-insulin relationship. The insulin-glucose example suggests that we may have to carefully re-examine causal inferences from perturbation experiments and set up revised norms for experimental design for causal inference.

© 2020 Diwekar-Joshi and Watve.

Keywords: Causality; Glucose homeostasis; Physiology; Steady state

Conflict of interest statement

The authors declare that they have no competing interests.

References

  1. Rev Neuropsychiatr Infant. 1966 Dec;14(12):315-7 - PubMed
  2. Can J Physiol Pharmacol. 2012 Jul;90(7):923-31 - PubMed
  3. Diabetes. 1986 Mar;35(3):258-67 - PubMed
  4. J Clin Invest. 2001 Oct;108(8):1205-13 - PubMed
  5. Mol Cell. 1998 Nov;2(5):559-69 - PubMed
  6. Am J Med. 1986 Dec 22;81(6B):88-93 - PubMed
  7. Nature. 2006 Oct 19;443(7113):870-4 - PubMed
  8. Metabolism. 1979 Sep;28(9):943-9 - PubMed
  9. J Clin Invest. 1972 Jul;51(7):1624-31 - PubMed
  10. Nat Commun. 2015 Sep 23;6:8250 - PubMed
  11. Biomed Pharmacother. 2017 May;89:1242-1251 - PubMed
  12. J Nutr Metab. 2012;2012:525093 - PubMed
  13. Diabetes. 1979 Apr;28(4):287-91 - PubMed
  14. Adv Exp Med Biol. 2015;872:99-126 - PubMed
  15. Cell Metab. 2012 Jun 6;15(6):873-84 - PubMed
  16. Diabetes. 2016 Aug;65(8):2187-200 - PubMed
  17. Cell Metab. 2014 Aug 5;20(2):201-3 - PubMed
  18. Diabetes Care. 2008 Feb;31 Suppl 2:S262-8 - PubMed
  19. Nature. 2014 Sep 18;513(7518):436-9 - PubMed
  20. Camb Q Healthc Ethics. 2015 Oct;24(4):407-19 - PubMed
  21. J Biol Chem. 2015 Aug 14;290(33):20044-59 - PubMed
  22. Diabetologia. 2015 Oct;58(10):2392-402 - PubMed
  23. J Cell Sci. 2001 Apr;114(Pt 8):1429-30 - PubMed
  24. Cell Rep. 2017 Jul 11;20(2):451-463 - PubMed
  25. Proc R Soc Med. 1965 May;58:295-300 - PubMed
  26. J Endocrinol Invest. 2002 Jun;25(6):502-7 - PubMed
  27. Eur J Pharmacol. 2002 Oct 18;453(1):141-8 - PubMed
  28. Diabetol Metab Syndr. 2015 Dec 21;7:115 - PubMed
  29. Horm Metab Res. 1988 Mar;20(3):168-70 - PubMed
  30. Diabetes. 2011 Apr;60(4):1324-8 - PubMed
  31. Science. 2005 Jan 21;307(5708):375-9 - PubMed
  32. J Pharm Pharmacol. 2008 Sep;60(9):1161-5 - PubMed
  33. Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S2-8 - PubMed
  34. Indian J Clin Biochem. 2007 Sep;22(2):60-4 - PubMed
  35. Diabetes. 2012 Jan;61(1):4-13 - PubMed
  36. Diabetologia. 1992 Sep;35(9):835-43 - PubMed
  37. Diabetes Res Clin Pract. 1991 Oct;14(1):47-54 - PubMed
  38. Lancet. 1998 Sep 12;352(9131):837-53 - PubMed
  39. Endocrinology. 2016 Jul;157(7):2724-34 - PubMed
  40. Int J Mol Med. 2007 Jan;19(1):65-73 - PubMed
  41. Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7361-8 - PubMed
  42. Diabetologia. 2000 May;43(5):533-49 - PubMed
  43. Diabetes. 2007 Jun;56(6):1703-11 - PubMed
  44. J Clin Endocrinol Metab. 2016 Dec;101(12):4825-4833 - PubMed
  45. J Biol Chem. 1972 May 25;247(10):3229-35 - PubMed
  46. Diabetologia. 2008 Jan;51(1):39-46 - PubMed
  47. J Clin Invest. 1969 Oct;48(10):1878-87 - PubMed
  48. Diabetes Care. 2012 Dec;35(12):2438-42 - PubMed
  49. PLoS One. 2010 Feb 24;5(2):e9328 - PubMed
  50. Gen Physiol Biophys. 1999 Oct;18 Spec No:54-62 - PubMed
  51. Sci Rep. 2017 Oct 5;7(1):12724 - PubMed
  52. Am J Physiol. 1993 Jan;264(1 Pt 1):E119-27 - PubMed
  53. Eur Surg Res. 2006;38(4):377-84 - PubMed
  54. Dev Sci. 2008 Nov;11(6):F31-9 - PubMed
  55. Proc Natl Acad Sci U S A. 2007 May 22;104(21):8977-82 - PubMed
  56. Diabetes. 2009 Apr;58(4):820-8 - PubMed
  57. Cell Metab. 2012 Dec 5;16(6):723-37 - PubMed
  58. Physiol Res. 2001;50(6):537-46 - PubMed
  59. PLoS One. 2017 Aug 2;12(8):e0181536 - PubMed
  60. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4162-7 - PubMed
  61. Diabetes. 1989 Dec;38(12):1512-27 - PubMed
  62. Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E41-9 - PubMed
  63. Am J Physiol Gastrointest Liver Physiol. 2008 Mar;294(3):G679-86 - PubMed
  64. Horm Res. 2004;62 Suppl 1:77-82 - PubMed
  65. Br J Clin Pharmacol. 1999 Nov;48(5):643-8 - PubMed
  66. Diabetes. 2000 Dec;49(12):2126-34 - PubMed
  67. Diabetes Care. 1981 May-Jun;4(3):366-76 - PubMed
  68. Nat Genet. 1998 Nov;20(3):294-8 - PubMed
  69. Clin Invest Med. 1996 Jun;19(3):149-60 - PubMed
  70. N Engl J Med. 2008 Jun 12;358(24):2545-59 - PubMed
  71. J Clin Endocrinol Metab. 2002 Apr;87(4):1797-804 - PubMed
  72. Sci Rep. 2018 Jun 7;8(1):8715 - PubMed
  73. Sports Med. 1991 Feb;11(2):102-24 - PubMed
  74. Am J Med. 1985 Aug 23;79(2B):6-12 - PubMed
  75. Horm Res. 2005;64 Suppl 3:8-15 - PubMed
  76. J R Soc Med. 2009 Mar;102(3):120-2 - PubMed
  77. J Clin Endocrinol Metab. 2011 Aug;96(8):2405-13 - PubMed
  78. Invest Ophthalmol Vis Sci. 2011 Jun 21;52(7):4402-9 - PubMed
  79. Diabetologia. 2004 Mar;47(3):407-411 - PubMed
  80. Diabetes. 1994 Feb;43(2):173-9 - PubMed
  81. Nature. 2014 Jul 3;511(7507):94-8 - PubMed
  82. Diabetes. 2001 Feb;50 Suppl 1:S160-3 - PubMed
  83. Metabolism. 2018 Nov;88:1-11 - PubMed
  84. Am J Physiol Endocrinol Metab. 2009 Oct;297(4):E836-48 - PubMed
  85. Math Biosci. 2013 Aug;244(2):69-81 - PubMed
  86. Circ Res. 2012 Sep 28;111(8):991-1001 - PubMed
  87. Scand J Gastroenterol Suppl. 1986;119:73-83 - PubMed
  88. Altern Lab Anim. 2018 Mar;46(1):13-22 - PubMed
  89. Pharmacol Rev. 2003 Mar;55(1):105-31 - PubMed
  90. Clin Endocrinol (Oxf). 1986 Dec;25(6):739-47 - PubMed
  91. Diabetes. 1970;19:Suppl:789-830 - PubMed
  92. Metabolism. 1979 Nov;28(11):1086-96 - PubMed
  93. Vitam Horm. 2009;80:635-48 - PubMed
  94. Endocr Rev. 1998 Oct;19(5):608-24 - PubMed
  95. Dev Cell. 2002 Jul;3(1):25-38 - PubMed
  96. Homo. 2016 Oct;67(5):349-368 - PubMed
  97. N Engl J Med. 1996 Jan 25;334(4):246-54 - PubMed
  98. J Diabetes Res. 2015;2015:341583 - PubMed
  99. Am J Physiol Endocrinol Metab. 2008 Apr;294(4):E679-87 - PubMed
  100. Diabetologia. 1990 May;33(5):285-9 - PubMed
  101. Diabetes Obes Metab. 2008 Dec;10(12):1195-203 - PubMed
  102. J Phys Chem B. 2020 Apr 23;124(16):3371-3386 - PubMed
  103. Biochem Pharmacol. 1989 Apr 15;38(8):1217-29 - PubMed
  104. Diabetes. 2007 Oct;56(10):2442-8 - PubMed
  105. Diabetes. 2000 Dec;49(12):2094-101 - PubMed
  106. FASEB J. 2018 Mar;32(3):1196-1206 - PubMed
  107. PLoS One. 2011;6(6):e20818 - PubMed
  108. Ann N Y Acad Sci. 2013 Apr;1281:51-63 - PubMed
  109. PLoS One. 2018 Oct 11;13(10):e0204755 - PubMed
  110. Cell Metab. 2009 Apr;9(4):350-61 - PubMed
  111. J Endocrinol Invest. 1988 Jan;11(1):21-6 - PubMed
  112. Exp Diabetes Res. 2008;2008:704045 - PubMed
  113. Mol Cell. 2000 Jul;6(1):87-97 - PubMed
  114. Am J Physiol Endocrinol Metab. 2001 May;280(5):E788-96 - PubMed
  115. Diabetes Obes Metab. 2005 May;7(3):239-45 - PubMed
  116. Cogn Psychol. 2019 Dec;115:101238 - PubMed
  117. Diabetes. 1988 Dec;37(12):1595-607 - PubMed
  118. Diabetologia. 1985 Jul;28(7):412-9 - PubMed
  119. Genetics. 1923 May;8(3):256-60 - PubMed
  120. Ann Intern Med. 1998 Feb 1;128(3):165-75 - PubMed
  121. Cell Metab. 2017 Feb 7;25(2):448-462 - PubMed
  122. BMJ. 1998 Sep 12;317(7160):703-13 - PubMed
  123. BMJ. 1999 Jul 24;319(7204):215-20 - PubMed
  124. Diabetes Obes Metab. 2007 Jul;9(4):566-74 - PubMed
  125. Diabet Med. 2013 Jan;30(1):35-42 - PubMed
  126. Diabetes. 2003 Jan;52(1):102-10 - PubMed
  127. Proc Natl Acad Sci U S A. 1997 May 13;94(10):5137-40 - PubMed
  128. J Steroid Biochem Mol Biol. 2010 Oct;122(1-3):21-7 - PubMed
  129. J Clin Invest. 1999 Nov;104(9):1257-64 - PubMed

Publication Types